SCHEMBL24333392

SCHEMBL24333392

CN(C)c1ccccc1S(=O)(=O)NC(=O)c1cc2c(F)cc(N3CCC3)cc2o1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 3/20 0.36
HRH1 P35367 1/20 0.36
CCR3 P51677 1/20 0.36
DCTPP1 Q9H773 1/20 0.35
MEN1 O00255 3/20 0.34
NLRP3 Q96P20 1/20 0.34
MAPT P10636 4/20 0.34
ALDH1A1 P00352 3/20 0.34
ATM Q13315 3/20 0.34
GAA P10253 1/20 0.34
GFER P55789 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MAPK1 P28482 1/20 0.34
SCN9A Q15858 1/20 0.33
HTR7 P34969 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
TP53 P04637 2/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29469667 1.00 KMT2A (0.36) KMT2ANPC1RAB9AHRH1CCR3
SCHEMBL29469686 0.92 NLRP3 (0.44) KMT2ANLRP3ATMHTR7NR3C1
SCHEMBL24334273 0.92 NLRP3 (0.44) KMT2ANLRP3ATMHTR7NR3C1
SCHEMBL24333403 0.88 KMT2A (0.35) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL29469648 0.86 KMT2A (0.36) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL24334215 0.86 KMT2A (0.37) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL31525463 0.85 KAT6A (0.41) KMT2AHRH1CCR3MAPTALDH1A1
SCHEMBL29469704 0.85 PARP1 (0.33) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL24333951 0.84 ALOX5AP (0.37) KMT2ANPC1RAB9AMEN1MAPT
SCHEMBL29469812 0.84 ALOX5AP (0.37) KMT2ANPC1RAB9AMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081807-A1 SUBSTITUTED ACYL SULFONAMIDES FOR TREATING CANCER THE BROAD INSTITUTE, INC. (US) 2022-04-21 WO disclosed